We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVID icon
7176
Ovid Therapeutics
OVID
$439M
$5K ﹤0.01%
1,486
-499
-25% -$1.13K
OXSQ icon
7177
Oxford Square Capital
OXSQ
$148M
$5K ﹤0.01%
864
PMO
7178
Franklin Municipal Opportunities Trust
PMO
$282M
$5K ﹤0.01%
400
-9,936
-96% -$130K
PNI
7179
PIMCO New York Municipal Income Fund II
PNI
$76.7M
$5K ﹤0.01%
450
PSCI icon
7180
Invesco S&P SmallCap Industrials ETF
PSCI
$186M
$5K ﹤0.01%
70
QNRX
7181
Quoin Pharmaceuticals
QNRX
$8.62M
0
QWLD
7182
State Street SPDR MSCI World StrategicFactors ETF
QWLD
$173M
$5K ﹤0.01%
+61
New +$4.87K
RMBI icon
7183
Richmond Mutual Bancorp
RMBI
$247M
$5K ﹤0.01%
+362
New +$4.84K
RNAC icon
7184
Cartesian Therapeutics
RNAC
$229M
$5K ﹤0.01%
94
-211
-69% -$11.2K
SBSW icon
7185
Sibanye-Stillwater
SBSW
$6.05B
$5K ﹤0.01%
917
-932
-50% -$4.75K
SCPH
7186
DELISTED
scPharmaceuticals
SCPH
$5K ﹤0.01%
767
-258
-25% -$1.46K
SOHO
7187
DELISTED
Sotherly Hotels
SOHO
$5K ﹤0.01%
749
SSTI icon
7188
SoundThinking
SSTI
$109M
$5K ﹤0.01%
205
-582
-74% -$18.9K
SYBX
7189
DELISTED
Synlogic
SYBX
$5K ﹤0.01%
142
-164
-54% -$11.9K
TLTD icon
7190
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$658M
$5K ﹤0.01%
81
-175
-68% -$10.4K
XPEL icon
7191
XPEL
XPEL
$1.18B
$5K ﹤0.01%
+400
New +$3.59K
PFIE
7192
DELISTED
Profire Energy, Inc
PFIE
$5K ﹤0.01%
2,697
-906
-25% -$1.38K
LUMO
7193
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$5K ﹤0.01%
365
-311
-46% -$4.56K
CMLS
7194
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$5K ﹤0.01%
361
-3,263
-90% -$49K
BCEL
7195
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$5K ﹤0.01%
+389
New +$5.91K
BFX
7196
DELISTED
BowFlex Inc.
BFX
$5K ﹤0.01%
3,370
-19,387
-85% -$30.4K
RVLP
7197
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$5K ﹤0.01%
1,300
-741
-36% -$2.51K
OFED
7198
DELISTED
Oconee Federal Financial Corp.
OFED
$5K ﹤0.01%
204
-69
-25% -$1.59K
ACOR
7199
PUT
DELISTED
Acorda Therapeutics
ACOR
$5K ﹤0.01%
14
-46
-77% -$25K
BLCM
7200
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$5K ﹤0.01%
454
-1,651
-78% -$21.6K

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.